UBE2D3 regulated by WTAP-mediated m6A modification inhibits temozolomide chemosensitivity in glioblastoma
- Type
- Retraction
- Notice date
- 6/24/2026 0:00
- Journal
- Naunyn-Schmiedeberg's Archives of Pharmacology
- Publisher
- Springer - Nature Publishing Group
- Notice DOI
- 10.1007/s00210-026-05622-0
- Original paper DOI
- 10.1007/s00210-024-03327-w